SMi reports: There are two post-conference workshops taking place on the 5th June 2019, which will explain lyophilisation in its most simplistic terms.
US medical technology firm Recovery Force has received a $1.8m grant from the US National Institutes of Health to develop and clinically validate a device that aims to prevent occurrence of
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
